TSS:Rfhg 11772.1

Basic information about the TSS

---

TSS ID: rfhg_11772.1 TSS ID(Version3): hg_4962.1 hg_4961.1 Species: human Chr: chr1		Start: 145964676 End: 145964737 Strand: +
Source datasets	FANTOM5|DRA000914|ENCODE|RAMPAGE|PRJNA615891|PRJNA597322 |PRJNA401781|PRJNA548673|PRJNA4843412|DRA013844
Protocol	CAGE|RAMPAGE|TIF-seq2|STRIPE-seq|oligo_capping |ReCappable-seq|SLIC_CAGE|NETCAGE
TSS cluster detected*	14

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2219329,EH38E1382275)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000369314.2:0 ENST00000622508.4:0 ENST00000369313.7:0 ENST00000471706.1:0 BC050418:0 BC004355:0 AK056984:0 AK092209:0 GeneID: 84265 HGNC/MGI_ID: HGNC:28466 UniProt_ID: A6NGX6 Q9BT43 Nearer transcript ids and distances:

Gene_name: RNA polymerase III subunit GL Gene_symbol: POLR3GL Gene_synonyms: MGC3200 flj32422 Gene_source: HGNC:28466

TATA-Box annotation

---

Distance to TSS:	16
Nearest PromoterID:	NM_032305
Entrez ID:	84265
Nearest Unigene:	Hs.591456
Nearest Refseq:	NM_032305
Nearest Ensembl:	ENSG00000121851
Gene Name:	RNA polymerase III subunit GL
Gene Alias:	RPC32HOM|flj32422
Gene Type:	protein-coding
CpG%:	0.098361
GC%:	0.596774
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@POLR3GL p2@POLR3GL
Sample		p1@POLR3GL	p2@POLR3GL
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	3.51	2.73
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	3.64	4.05
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	4.05	3.67
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	2.29	2.29
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	1.57	2.47
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	1.74	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	5.45	3.70
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	3.88	5.09
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	3.42	5.77
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.06	6.38
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	4.85	10.11
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	4.88	6.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	9.67	5.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	9.62	6.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.66	7.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	7.29	5.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	9.17	5.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.01	5.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	10.13	7.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.18	4.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.82	4.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	7.42	6.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	7.63	5.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	10.92	4.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	8.77	4.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.50	6.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.69	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.84	8.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	8.24	6.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	10.13	5.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.65	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	6.84	4.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	6.12	4.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.20	6.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.98	4.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	6.13	5.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.38	5.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	8.87	4.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	10.53	4.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	9.12	6.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.53	5.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.49	7.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	7.17	3.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	5.59	4.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	6.42	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	7.68	5.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.00	5.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	7.45	5.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	4.31	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.67	4.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	4.30	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	5.34	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	83.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	3.19	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.61	5.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	11.75	14.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.73	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	5.19	3.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	1.93	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	9.12	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	5.64	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.61	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	16.72	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	8.83	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	3.25	4.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.10	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	96.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	78.97	71.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	9.26	7.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	14.38	7.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	11.26	5.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.59	6.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.68	6.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.56	6.11
Adipocyte - breast, donor1	11376-118A8	21.86	16.47
Adipocyte - breast, donor2	11327-117E4	22.78	17.01
Adipocyte - omental, donor1	11473-119C6	26.85	22.14
Adipocyte - omental, donor2	11474-119C7	21.68	12.71
Adipocyte - omental, donor3	11475-119C8	21.43	11.39
Adipocyte - perirenal, donor1	11476-119C9	15.95	15.31
Adipocyte - subcutaneous, donor1	11259-116F8	18.69	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	12.19	8.58
Adipocyte - subcutaneous, donor3	11408-118E4	14.60	8.52
Adipocyte differentiation, day04, donor1	13019-139D4	21.90	17.80
Adipocyte differentiation, day04, donor2	13022-139D7	18.27	9.01
Adipocyte differentiation, day04, donor3	13025-139E1	24.53	12.27
Adipocyte differentiation, day04, donor4	13028-139E4	29.39	9.40
Adipocyte differentiation, day08, donor1	13020-139D5	27.59	16.49
Adipocyte differentiation, day08, donor2	13023-139D8	29.69	14.20
Adipocyte differentiation, day08, donor3	13026-139E2	21.33	13.86
Adipocyte differentiation, day08, donor4	13029-139E5	19.48	9.46
Adipocyte differentiation, day12, donor1	13021-139D6	27.86	14.56
Adipocyte differentiation, day12, donor2	13024-139D9	19.84	14.07
Adipocyte differentiation, day12, donor3	13027-139E3	19.63	10.80
Adipocyte differentiation, day12, donor4	13030-139E6	19.18	9.74
Alveolar Epithelial Cells, donor1	11510-119G7	9.94	8.40
Alveolar Epithelial Cells, donor2	11590-120G6	5.02	3.23
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	5.99
Amniotic Epithelial Cells, donor1	11533-120A3	12.41	8.64
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	8.37
Amniotic Epithelial Cells, donor3	11694-123A2	12.74	10.48
Anulus Pulposus Cell, donor1	11248-116E6	44.63	26.09
Anulus Pulposus Cell, donor2	11463-119B5	25.47	10.53
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	18.87	10.78
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	24.31	13.46
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	25.68	14.98
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	27.50	10.16
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	30.35	12.65
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	14.52	8.58
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	23.07	8.77
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	24.27	9.22
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.22	13.07
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.96	10.92
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.04	11.61
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	11.28
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	19.44	10.71
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	23.20	12.28
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	11.76	7.99
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	28.93	10.18
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	17.19	9.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	18.98	9.62
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	22.44	8.78
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	17.25	10.62
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	9.61
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	14.16
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	16.81	11.84
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	22.33	9.71
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.97	14.42
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	14.54
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.96	11.97
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	15.61	9.19
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	16.52	8.78
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	28.62	10.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	15.11	11.25
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.84	11.42
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.23	10.53
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.97	10.54
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	16.63	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	26.95	15.77
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	17.32	13.24
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	11.44	9.53
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.44	12.08
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.88	9.53
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	13.05	5.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	9.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	19.50	10.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	13.90
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	10.56
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	14.15	9.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.85	9.63
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	24.06	9.48
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	18.62	6.44
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	10.20
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	10.42	7.88
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.75	9.70
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.38	5.81
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	19.60	9.08
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	14.41	10.64
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	19.39	9.42
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	19.33	8.47
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.54	5.09
Astrocyte - cerebellum, donor1	11500-119F6	39.30	15.47
Astrocyte - cerebellum, donor2	11580-120F5	21.39	16.26
Astrocyte - cerebellum, donor3	11661-122F5	16.36	7.76
Astrocyte - cerebral cortex, donor1	11235-116D2	32.77	14.99
Astrocyte - cerebral cortex, donor2	11316-117D2	25.40	16.18
Astrocyte - cerebral cortex, donor3	11392-118C6	21.18	15.81
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	38.76	17.32
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	37.46	13.78
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	36.41	17.18
Basophils, donor1	12241-129G9	20.66	18.83
Basophils, donor2	12242-129H1	31.39	24.17
Basophils, donor3	12243-129H2	17.79	17.35
Bronchial Epithelial Cell, donor1	11511-119G8	8.41	9.27
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	1.83
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	3.14	4.39
Bronchial Epithelial Cell, donor5	11457-119A8	3.95	3.33
Bronchial Epithelial Cell, donor6	11461-119B3	5.76	7.60
Bronchial Epithelial Cell, donor7	11769-123I5	13.14	10.62
Burkitt's lymphoma cell line:DAUDI	10422-106C8	32.57	60.60
Burkitt's lymphoma cell line:RAJI	10476-106I8	20.50	24.45
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	37.73	29.42
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	62.05
CD14+ Monocytes, donor1	11224-116B9	19.72	15.22
CD14+ Monocytes, donor2	11305-117B9	21.34	14.48
CD14+ Monocytes, donor3	11381-118B4	18.00	13.17
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	37.93	35.38
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	36.01	29.57
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	48.00	37.81
CD14+ monocytes - mock treated, donor1	11863-125A9	9.25	6.50
CD14+ monocytes - mock treated, donor2	11873-125C1	4.53	4.22
CD14+ monocytes - mock treated, donor3	11883-125D2	7.34	4.26
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.02	4.18
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3.59	1.66
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2.98	3.97
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.85	3.13
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.81	1.42
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.44	3.48
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.38	3.51
CD14+ monocytes - treated with Candida, donor2	11878-125C6	7.39	4.75
CD14+ monocytes - treated with Candida, donor3	11888-125D7	6.66	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	7.59	2.97
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2.99	2.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.75	4.37
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	4.35	3.20
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	3.85	3.62
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.06	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	8.61	2.96
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	4.54	2.79
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.89	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.76	2.20
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.76	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.07	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.85	2.62
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3.72	2.60
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	8.84	5.39
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.91	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.85	2.32
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.25	1.86
CD14+CD16+ Monocytes, donor1	11789-124B7	32.26	19.40
CD14+CD16+ Monocytes, donor2	11801-124D1	30.26	21.25
CD14+CD16+ Monocytes, donor3	11912-125G4	30.54	24.48
CD14+CD16- Monocytes, donor1	11788-124B6	29.74	24.29
CD14+CD16- Monocytes, donor2	11799-124C8	26.37	20.43
CD14+CD16- Monocytes, donor3	11910-125G2	43.70	28.32
CD14-CD16+ Monocytes, donor1	11790-124B8	30.11	23.22
CD14-CD16+ Monocytes, donor2	11800-124C9	29.86	21.52
CD14-CD16+ Monocytes, donor3	11911-125G3	29.90	17.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	81.29	65.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	61.70	68.48
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	47.64	61.10
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	45.84	69.83
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	60.04	97.03
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	57.56	65.98
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	43.14	87.06
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	63.28	100.19
CD19+ B Cells, donor1	11544-120B5	20.55	34.52
CD19+ B Cells, donor2	11624-122B4	19.59	21.04
CD19+ B Cells, donor3	11705-123B4	20.19	33.82
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	96.97	37.58
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	59.12	23.97
CD34+ Progenitors, donor1	11545-120B6	16.06	20.08
CD34+ Progenitors, donor2	11625-122B5	12.92	14.61
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	45.09	30.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	52.09	32.24
CD4+ T Cells, donor1	11225-116C1	47.13	51.42
CD4+ T Cells, donor2	11306-117C1	44.09	40.42
CD4+ T Cells, donor3	11382-118B5	45.44	46.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	78.36	86.78
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	79.28	66.03
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	85.09	85.66
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	64.00	74.43
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	86.39	101.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	69.22	98.89
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	79.77	61.71
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	57.11	49.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	54.33	44.65
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	75.76	74.42
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	77.56	78.26
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	68.20	66.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	75.05	48.49
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	50.70	37.61
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	48.45	36.75
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	79.40	79.95
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	86.82	82.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	102.21	55.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	71.39	56.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	61.74	54.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	72.50	51.28
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	70.78	64.21
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	66.72	69.75
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	87.16	66.68
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	100.46	86.60
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	87.70	85.86
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	111.67	114.46
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	119.08	95.54
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	137.17	111.65
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	97.02	78.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	96.69	100.99
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	112.18	84.48
CD8+ T Cells, donor1	11226-116C2	43.87	45.51
CD8+ T Cells, donor2	11307-117C2	40.92	34.92
CD8+ T Cells, donor3	11383-118B6	40.90	42.92
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.96	5.51
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.67	4.07
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.47	5.20
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	10.51	4.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.48	2.40
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	6.82	3.18
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.47	3.26
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	8.69	3.95
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.27	3.75
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	10.87	5.74
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	9.59	4.94
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	6.39	5.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	4.82	4.38
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	5.47	4.55
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	4.48	6.71
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.04	2.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	10.93	4.89
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	6.36	2.12
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	8.24	4.75
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	6.77	5.84
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	6.09	4.49
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.65	5.35
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.49	6.31
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.86	6.05
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	12.85	11.24
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	13.99	11.19
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	9.02	15.03
Cardiac Myocyte, donor1	11525-119I4	5.48	3.66
Cardiac Myocyte, donor2	11605-120I3	17.29	18.28
Cardiac Myocyte, donor3	11686-122I3	16.31	15.68
Chondrocyte - de diff, donor1	11261-116G1	19.76	7.28
Chondrocyte - de diff, donor2	11338-117F6	13.50	3.91
Chondrocyte - de diff, donor3	11410-118E6	20.03	10.92
Chondrocyte - re diff, donor2	11339-117F7	62.67	25.07
Chondrocyte - re diff, donor3	11411-118E7	20.22	9.71
Ciliary Epithelial Cells, donor1	11242-116D9	40.62	28.35
Ciliary Epithelial Cells, donor2	11323-117D9	27.79	19.88
Ciliary Epithelial Cells, donor3	11399-118D4	23.89	17.79
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	31.91	16.41
Corneal Epithelial Cells, donor1	11526-119I5	5.93	9.22
Corneal Epithelial Cells, donor2	11606-120I4	2.28	3.41
Corneal Epithelial Cells, donor3	11687-122I4	10.74	6.39
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	20.47	14.86
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	14.19	14.82
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	31.06
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	16.31	13.71
Dendritic Cells - plasmacytoid, donor1	11228-116C4	23.91	12.98
Dendritic Cells - plasmacytoid, donor2	11309-117C4	20.24	13.06
Dendritic Cells - plasmacytoid, donor3	11385-118B8	29.52	15.00
Endothelial Cells - Aortic, donor0	11207-116A1	13.84	8.17
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	4.69
Endothelial Cells - Aortic, donor2	11340-117F8	14.42	8.20
Endothelial Cells - Aortic, donor3	11412-118E8	17.30	4.33
Endothelial Cells - Artery, donor1	11264-116G4	13.38	9.60
Endothelial Cells - Artery, donor2	11341-117F9	16.23	7.06
Endothelial Cells - Artery, donor3	11413-118E9	8.59	6.31
Endothelial Cells - Lymphatic, donor1	11236-116D3	16.40	11.53
Endothelial Cells - Lymphatic, donor2	11317-117D3	17.95	12.17
Endothelial Cells - Lymphatic, donor3	11393-118C7	17.20	10.71
Endothelial Cells - Microvascular, donor1	11265-116G5	17.53	11.29
Endothelial Cells - Microvascular, donor2	11342-117G1	10.93	8.33
Endothelial Cells - Microvascular, donor3	11414-118F1	20.13	14.04
Endothelial Cells - Thoracic, donor1	11266-116G6	18.01	11.20
Endothelial Cells - Thoracic, donor2	11343-117G2	18.34	4.72
Endothelial Cells - Umbilical vein, donor1	11243-116E1	42.49	31.43
Endothelial Cells - Umbilical vein, donor2	11324-117E1	30.42	19.55
Endothelial Cells - Umbilical vein, donor3	11400-118D5	29.07	21.62
Endothelial Cells - Vein, donor1	11267-116G7	3.41	7.96
Endothelial Cells - Vein, donor2	11344-117G3	6.99	6.29
Endothelial Cells - Vein, donor3	11416-118F3	12.87	5.50
Eosinophils, donor1	12244-129H3	45.74	30.49
Eosinophils, donor2	12245-129H4	8.25	19.80
Eosinophils, donor3	12246-129H5	14.27	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	10.26	7.82
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.96	7.80
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	11.72	8.10
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	18.09	8.88
Fibroblast - Aortic Adventitial, donor1	11245-116E3	22.92	15.89
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	11.19	8.46
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.46	9.39
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	15.55	5.01
Fibroblast - Aortic Adventitial, donor3	11401-118D6	20.93	11.29
Fibroblast - Cardiac, donor1	11268-116G8	7.71	4.08
Fibroblast - Cardiac, donor2	11345-117G4	5.31	3.03
Fibroblast - Cardiac, donor3	11417-118F4	12.46	8.36
Fibroblast - Cardiac, donor4	11452-119A3	22.13	13.94
Fibroblast - Cardiac, donor5	11456-119A7	19.16	9.77
Fibroblast - Cardiac, donor6	11460-119B2	14.40	6.67
Fibroblast - Choroid Plexus, donor1	11492-119E7	35.64	19.83
Fibroblast - Choroid Plexus, donor2	11572-120E6	13.81	8.63
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	8.79
Fibroblast - Conjunctival, donor1	11531-120A1	35.75	32.75
Fibroblast - Conjunctival, donor3	11692-122I9	34.77	18.49
Fibroblast - Dermal, donor1	11269-116G9	17.84	17.14
Fibroblast - Dermal, donor2	11346-117G5	15.57	14.62
Fibroblast - Dermal, donor3	11418-118F5	26.11	19.95
Fibroblast - Dermal, donor4	11450-119A1	28.15	20.69
Fibroblast - Dermal, donor5	11454-119A5	28.61	19.36
Fibroblast - Dermal, donor6	11458-119A9	27.77	18.68
Fibroblast - Gingival, donor1	11237-116D4	33.94	60.39
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	45.33	23.32
Fibroblast - Gingival, donor2	11318-117D4	35.98	23.46
Fibroblast - Gingival, donor3	11394-118C8	43.22	50.95
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	9.35
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	21.67	9.16
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	38.82	20.11
Fibroblast - Gingival, donor6 (control)	11922-125H5	41.92	20.15
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	13.41	9.17
Fibroblast - Gingival, donor7 (control)	11924-125H7	36.41	12.43
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	39.27	19.63
Fibroblast - Gingival, donor8 (control)	11926-125H9	26.55	15.03
Fibroblast - Gingival, donor9 (control)	11927-125I1	30.96	12.77
Fibroblast - Lung, donor1	11270-116H1	8.16	8.16
Fibroblast - Lung, donor2	11347-117G6	20.89	8.95
Fibroblast - Lung, donor3	11419-118F6	24.27	14.77
Fibroblast - Lymphatic, donor1	11506-119G3	61.64	45.82
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	12.59
Fibroblast - Lymphatic, donor3	11667-122G2	12.87	12.59
Fibroblast - Mammary, donor1	11540-120B1	56.43	51.15
Fibroblast - Mammary, donor2	11620-122A9	23.97	11.98
Fibroblast - Mammary, donor3	11701-123A9	35.74	41.69
Fibroblast - Periodontal Ligament, donor1	11238-116D5	33.95	34.33
Fibroblast - Periodontal Ligament, donor2	11319-117D5	41.41	33.83
Fibroblast - Periodontal Ligament, donor3	11395-118C9	47.43	52.94
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.48	8.78
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	25.38	13.50
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.74	9.74
Fibroblast - Pulmonary Artery, donor1	11250-116E8	16.58	10.83
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	41.65	21.74
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	26.73	16.71
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	24.51	22.54
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	14.49	5.36
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	24.69	8.35
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	23.06	8.67
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	16.25	7.52
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	41.02	15.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	14.68	5.06
Fibroblast - skin normal, donor1	11553-120C5	29.53	13.13
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	11.83	7.22
Fibroblast - skin normal, donor2	11561-120D4	31.04	12.66
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	23.27	3.93
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	33.88	14.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	47.52	18.80
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	12.48	5.91
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	29.51	16.19
Fibroblast - skin walker warburg, donor1	11554-120C6	23.11	9.45
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	24.62	9.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	155.12	110.80
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	16.56	4.36
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.97	7.80
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	9.37	7.29
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	7.92	7.92
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	5.36	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	3.83	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	6.28	4.56
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	13.79	3.58
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	15.53	7.53
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	7.13	4.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.16	3.70
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	11.09	5.22
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	5.31	7.08
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	9.75	7.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	16.75	9.73
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	6.45	5.10
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	13.63	11.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	9.97	7.48
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	3.86	5.08
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	16.20	10.27
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	10.84	12.21
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	7.43	7.21
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	24.23	9.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	18.92	14.62
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	13.41	8.71
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	24.60	11.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	23.41	13.91
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	18.18	11.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	40.48	19.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.23	19.13
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	22.79	14.05
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	18.89	10.07
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.01	9.80
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	27.64	13.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	24.21	15.33
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	21.18	10.34
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	26.01	11.46
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	25.09	18.08
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	22.69	10.70
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	30.15	17.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.05	12.70
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	19.30	8.23
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	23.72	12.77
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	24.46	9.83
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.44	10.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	29.46	12.62
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	17.78	8.70
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	16.04	9.09
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	14.23	8.87
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	15.03	7.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	19.25	11.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	28.39	9.77
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	24.34	13.38
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	50.58	22.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	21.90	12.14
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	24.41	9.08
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	44.48	23.64
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	9.75	6.17
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	7.09	5.70
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	8.18	7.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.01	2.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.04	3.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	10.15	6.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	9.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	9.67	6.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	11.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	8.79	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	10.30	11.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.14	11.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	11.44	6.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	11.74	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	14.00	10.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	14.27	7.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	12.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	20.04	11.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	12.14	8.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	14.50	7.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	14.73	7.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	11.92	9.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	14.02	7.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	17.39	7.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	31.21	15.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	14.72	9.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	23.59	13.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	26.55	12.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	24.42	10.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	26.32	9.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	27.63	23.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	24.79	11.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	28.59	13.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	21.94	14.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	21.19	9.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	19.10	13.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.98	11.16
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	5.71
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	30.35	14.97
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	6.75
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	32.35	28.23
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	27.99	53.47
Hep-2 cells mock treated, biol_rep1	11898-125E8	12.88	4.53
Hep-2 cells mock treated, biol_rep2	11899-125E9	11.31	6.08
Hep-2 cells mock treated, biol_rep3	11900-125F1	13.20	5.69
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.10	5.90
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	12.89	3.01
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	11.84	4.74
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.21	5.11
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	11.84	6.35
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	11.53	5.13
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	24.06	14.55
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	13.85	8.66
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	10.58
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	19.75	15.87
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	20.34	17.44
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	17.13	8.39
Hepatocyte, donor1	11523-119I2	58.11	14.53
Hepatocyte, donor2	11603-120I1	32.32	10.77
Hepatocyte, donor3	11684-122I1	27.00	19.63
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	28.72	20.23
Intestinal epithelial cells (polarized), donor1	11246-116E4	22.37	19.23
Iris Pigment Epithelial Cells, donor1	11530-119I9	14.68	10.29
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	19.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	20.03
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	16.61
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	12.81
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	32.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	14.62	11.37
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	13.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	17.21	19.85
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	11.09	6.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	20.95
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.82	19.53
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	6.19
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	29.27
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	17.44	16.15
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	11.27
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	17.11	17.11
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	12.17	9.66
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.84	14.47
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	7.39
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	11.80	19.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	6.35	12.70
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	18.29	16.14
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	7.62	11.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	65.72
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	15.94	10.84
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	16.42	19.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	13.27	17.28
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	12.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	9.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	10.43	17.38
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	15.49
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	25.94
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	23.54	28.77
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	40.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	13.94
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	22.40	30.94
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	20.78	11.08
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	14.25
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	19.33	20.25
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	24.20
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	31.04
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	17.98	34.89
Keratinocyte - epidermal, donor1	11272-116H3	8.32	8.08
Keratinocyte - epidermal, donor2	11349-117G8	4.69	5.86
Keratinocyte - epidermal, donor3	11421-118F8	13.06	8.14
Keratinocyte - oral, donor1	11251-116E9	27.58	33.15
Keratocytes, donor1	11527-119I6	35.76	30.94
Keratocytes, donor2	11607-120I5	33.98	35.15
Keratocytes, donor3	11688-122I5	17.78	10.28
Krukenberg tumor cell line:HSKTC	10687-109F3	39.56	19.78
Lens Epithelial Cells, donor1	11529-119I8	8.63	10.79
Lens Epithelial Cells, donor2	11609-120I7	37.14	17.42
Lens Epithelial Cells, donor3	11690-122I7	20.69	16.45
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	32.02	14.58
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	27.63	13.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	34.47	15.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	23.66	22.05
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	20.49	11.98
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	27.38	10.35
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	29.96	9.03
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	17.19	9.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	27.87	10.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	27.69	9.89
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.20	11.25
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	14.07	6.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	25.78	15.68
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	25.76	14.31
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	22.53	8.38
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	20.33	9.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	20.58	9.35
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	25.62	13.36
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	29.29	11.85
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	21.67	7.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	22.15	6.72
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.88	14.55
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	26.66	10.77
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	29.22	10.75
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	21.25	15.03
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	26.59	14.03
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	26.01	10.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	18.57	6.88
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	22.01	10.72
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	25.45	8.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	26.65	11.63
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	16.54	9.59
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	23.17	10.41
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	26.28	11.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	21.25	9.88
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	18.97	8.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	27.34	10.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	31.04	8.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	30.37	13.44
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	19.56	11.02
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	21.33	6.79
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	16.34	6.69
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	26.14	13.25
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	21.89	10.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	16.01	8.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	25.25	14.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	17.16	5.38
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	25.06	10.14
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	40.79	11.33
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	15.34	3.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	17.81	5.20
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	17.35	8.04
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	18.99	5.63
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	12.14	14.01
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	13.40	6.70
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	16.65	13.08
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	19.23	8.60
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	23.27	6.40
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	24.31	9.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	20.46	10.30
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	16.43	5.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	20.11	8.82
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	20.66	6.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.87	8.15
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	24.55	10.14
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	20.78	7.37
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.25	10.43
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	17.12	6.52
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	23.12	12.70
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	24.66	8.97
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	12.36	5.15
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	19.16	8.42
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	19.13	7.17
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	21.58	7.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	12.02	5.66
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	18.07	5.90
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	17.27	6.91
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	22.26	10.36
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.12	4.53
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	17.23	7.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.10	6.33
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	16.52	5.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	18.67	13.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	18.21	8.18
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	13.35	6.03
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	26.55	6.85
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	21.66	10.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.08	4.83
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.77	9.24
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	14.44	7.56
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	17.71	4.83
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	11.45	6.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	18.52	8.15
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	16.28	11.63
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	19.04	8.46
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	17.21	6.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.26	7.27
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	28.36	9.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	12.83	14.31
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	22.58	7.53
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	16.59	6.03
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	12.62	7.66
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	16.03	8.46
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.03	7.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	11.88	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	14.01	6.23
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	16.19	6.13
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	15.10	8.39
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	12.37	6.18
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	13.89	9.64
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	10.63	4.05
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	14.42	6.73
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	15.90	5.57
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.76	10.94
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	12.45	4.15
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	13.30	6.84
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	11.36	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	9.67	7.86
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	16.16	8.56
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	11.73	6.40
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	22.99	4.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.74	7.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	19.81	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.92	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	12.06	6.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.79	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	17.12	4.59
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	11.15	5.58
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.05	8.03
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	23.52	6.95
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	21.01	10.10
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	15.60	6.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	11.56	7.11
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	11.97	9.69
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	8.44	4.60
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	14.23	4.92
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	10.69	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.18	4.94
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	16.58	3.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	6.24
Macrophage - monocyte derived, donor1	11232-116C8	24.61	19.83
Macrophage - monocyte derived, donor2	11313-117C8	18.35	15.05
Macrophage - monocyte derived, donor3	11389-118C3	24.77	18.48
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.97	7.43
Mallassez-derived cells, donor2	11929-125I3	11.88	11.41
Mallassez-derived cells, donor3	11930-125I4	12.09	10.70
Mammary Epithelial Cell, donor1	11273-116H4	15.74	18.63
Mammary Epithelial Cell, donor2	11350-117G9	10.42	10.13
Mammary Epithelial Cell, donor3	11422-118F9	2.74	2.99
Mast cell - stimulated, donor1	11487-119E2	135.59	105.08
Mast cell, donor1	11563-120D6	54.94	40.77
Mast cell, donor2	11565-120D8	73.40	43.39
Mast cell, donor3	11566-120D9	90.27	62.13
Mast cell, donor4	11567-120E1	73.93	49.64
Mast cell, expanded and stimulated, donor5	11940-126A5	62.32	28.17
Mast cell, expanded and stimulated, donor8	11942-126A7	44.94	22.76
Mast cell, expanded, donor5	11939-126A4	65.28	32.81
Mast cell, expanded, donor8	11941-126A6	66.44	49.04
Melanocyte - dark, donor1	11502-119F8	47.76	25.17
Melanocyte - dark, donor2	11582-120F7	22.84	12.46
Melanocyte - dark, donor3	11663-122F7	25.64	16.01
Melanocyte - light, donor1	11274-116H5	13.16	8.93
Melanocyte - light, donor2	11351-117H1	10.92	9.55
Melanocyte - light, donor3	11423-118G1	10.41	5.20
Melanocyte, donor1 (MC+1)	12641-134G4	19.99	14.89
Melanocyte, donor2 (MC+2)	12739-135I3	21.25	12.91
Melanocyte, donor3 (MC+3)	12837-137B2	39.37	27.32
Meningeal Cells, donor1	11493-119E8	51.11	31.14
Meningeal Cells, donor2	11573-120E7	42.25	18.93
Meningeal Cells, donor3	11654-122E7	27.06	18.01
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	35.93	23.10
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	13.99	7.14
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	13.14
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	18.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.79	5.74
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	17.36	12.28
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	24.13	15.08
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	26.81	20.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	21.19	17.53
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	17.80	16.16
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	33.10	16.34
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	10.78	3.35
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	20.53	19.47
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.95	6.23
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	7.01
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	24.98	23.05
Mesenchymal stem cells - adipose, donor0	11217-116B2	14.53	6.73
Mesenchymal stem cells - hepatic, donor0	11218-116B3	17.20	14.70
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.77	22.50
Mesothelial Cells, donor1	11247-116E5	17.24	14.32
Mesothelial Cells, donor2	12156-128G5	16.52	16.01
Mesothelial Cells, donor3	11402-118D7	13.15	11.92
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	39.16	27.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	18.47	17.98
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	22.08	16.20
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	10.37
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	21.08	14.26
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	17.84	14.31
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	20.77	17.02
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	20.95	16.29
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	18.49	14.83
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	15.44	16.63
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	17.10
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	12.39	9.73
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	17.86	15.96
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	14.47
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	16.55	11.04
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	3.68
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	16.99	9.24
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	11.74
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	18.82	11.29
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.74	15.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	8.85
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	12.43	10.82
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	13.25	11.99
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	13.25	9.17
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	19.74	10.94
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	14.45	15.34
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.29	6.79
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.17	5.58
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	9.78	7.88
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.59	11.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	3.27
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	6.25	4.32
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	12.81	8.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.51	7.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.01	9.20
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	5.52
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	3.20
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	8.43	4.71
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.74	4.87
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	14.02	8.21
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.50	8.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.68	3.91
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	15.71	11.78
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.47	14.13
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	7.58	5.83
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.69	9.95
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	14.19	20.87
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	15.70	11.08
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	22.76
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	17.00	13.13
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.22	15.81
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.02	20.59
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.72	15.24
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	17.08	16.55
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	26.04	23.95
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.15	10.59
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.97	15.61
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	16.81	29.19
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	14.03	9.86
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	19.89	17.33
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	21.63	22.12
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.73	5.21
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	26.17	15.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	24.22	25.37
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	31.74	23.08
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	27.40	23.23
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	8.91
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	20.04	16.10
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	15.78
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	19.18	15.62
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	30.73	17.70
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	29.67	17.27
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	21.57	10.65
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	21.94	12.78
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.79	7.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	19.05	12.09
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	14.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	29.39	16.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	10.10
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	19.82	21.93
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	21.79	19.07
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	26.70	24.80
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	37.25	26.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	19.64	10.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	19.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	33.27
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	17.23	8.83
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	33.97	9.41
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.01	5.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.01	4.59
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	15.02	7.23
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	38.30	20.75
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	3.40
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	22.05	20.21
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.63	3.77
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	8.83	7.21
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.27	5.13
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	25.23	15.35
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	289.50	133.62
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	17.37	9.93
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.59	6.77
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.47	6.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.14	4.57
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	22.42	8.02
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.43	5.83
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.20	3.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	26.58	10.50
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5.85	5.20
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	27.52	9.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	8.44	3.52
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.79	7.82
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.60	5.78
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	15.86	12.42
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	78.38	35.40
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	23.17	12.70
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.04	5.08
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	13.53	5.93
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	12.45	6.44
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	153.47	135.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.66	4.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.47	5.41
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.75	2.38
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	10.22	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.51	6.81
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	6.19	2.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.54	4.36
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	20.35	13.12
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	6.17	4.41
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.31	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	11.41	5.95
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.95	3.06
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.01	6.35
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	20.78	13.48
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.23	6.78
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	97.08	61.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.80	3.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.24	4.41
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.08	3.63
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	16.61	7.91
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	28.34	10.20
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	70.81
Myoblast, donor1	11241-116D8	15.53	15.16
Myoblast, donor2	11322-117D8	20.71	10.93
Myoblast, donor3	11398-118D3	19.84	20.52
NK T cell leukemia cell line:KHYG-1	10777-110G3	32.40	41.74
Natural Killer Cells, donor1	11230-116C6	44.28	44.59
Natural Killer Cells, donor2	11311-117C6	35.58	42.82
Natural Killer Cells, donor3	11387-118C1	37.92	37.36
Neural stem cells, donor1	11275-116H6	63.51	22.87
Neural stem cells, donor2	11352-117H2	51.99	19.26
Neurons, donor1	11494-119E9	17.07	7.97
Neurons, donor2	11574-120E8	31.48	14.09
Neurons, donor3	11655-122E8	12.33	4.11
Neutrophils, donor1	11233-116C9	25.06	28.77
Neutrophils, donor2	11314-117C9	17.39	20.29
Neutrophils, donor3	11390-118C4	29.32	31.15
Nucleus Pulposus Cell, donor1	11252-116F1	29.45	17.22
Nucleus Pulposus Cell, donor2	11409-118E5	29.96	19.21
Nucleus Pulposus Cell, donor3	11462-119B4	19.45	6.82
Olfactory epithelial cells, donor1	11933-125I7	15.14	6.88
Olfactory epithelial cells, donor2	11934-125I8	16.50	12.30
Olfactory epithelial cells, donor3	11935-125I9	19.86	12.15
Olfactory epithelial cells, donor4	11936-126A1	22.30	11.30
Oligodendrocyte - precursors, donor1	11496-119F2	19.26	17.45
Osteoblast - differentiated, donor1	11276-116H7	21.27	10.42
Osteoblast - differentiated, donor2	11353-117H3	28.58	9.14
Osteoblast - differentiated, donor3	11425-118G3	16.76	8.07
Osteoblast, donor1	11277-116H8	11.73	8.79
Osteoblast, donor2	11354-117H4	21.77	9.13
Osteoblast, donor3	11426-118G4	17.42	10.66
Pancreatic stromal cells, donor1	11249-116E7	33.61	21.48
Pericytes, donor1	11491-119E6	17.80	11.68
Pericytes, donor2	11571-120E5	20.60	10.41
Pericytes, donor3	11652-122E5	20.96	13.02
Perineurial Cells, donor1	11499-119F5	27.58	17.18
Perineurial Cells, donor2	11579-120F4	26.13	20.61
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	49.72	44.30
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	24.00	23.51
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	33.52	26.40
Placental Epithelial Cells, donor1	11278-116H9	5.50	9.57
Placental Epithelial Cells, donor2	11355-117H5	14.42	13.31
Placental Epithelial Cells, donor3	11427-118G5	12.96	8.83
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	9.49	6.01
Preadipocyte - breast, donor1	11467-119B9	17.82	10.50
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9.40	4.44
Preadipocyte - breast, donor2	11328-117E5	20.94	9.68
Preadipocyte - omental, donor1	11468-119C1	22.06	12.25
Preadipocyte - omental, donor2	11329-117E6	27.06	15.28
Preadipocyte - omental, donor3	11403-118D8	16.90	13.32
Preadipocyte - perirenal, donor1	11469-119C2	20.67	13.78
Preadipocyte - subcutaneous, donor1	11279-116I1	7.68	7.06
Preadipocyte - subcutaneous, donor2	11356-117H6	25.14	11.51
Preadipocyte - subcutaneous, donor3	11428-118G6	24.01	9.54
Preadipocyte - visceral, donor1	11280-116I2	27.85	17.51
Preadipocyte - visceral, donor2	11357-117H7	22.55	12.42
Preadipocyte - visceral, donor3	11429-118G7	19.33	7.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	10.86	8.30
Prostate Epithelial Cells, donor2	11331-117E8	6.91	7.45
Prostate Epithelial Cells, donor3	11404-118D9	5.45	4.53
Prostate Stromal Cells, donor1	11254-116F3	15.72	11.16
Prostate Stromal Cells, donor2	11332-117E9	26.36	16.67
Prostate Stromal Cells, donor3	11405-118E1	21.06	11.26
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.77	5.47
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.15	11.64
Renal Epithelial Cells, donor1	11517-119H5	16.74	7.10
Renal Epithelial Cells, donor2	11597-120H4	12.09	7.11
Renal Epithelial Cells, donor3	11678-122H4	20.64	14.08
Renal Glomerular Endothelial Cells, donor1	11514-119H2	11.57	5.45
Renal Glomerular Endothelial Cells, donor2	11594-120H1	17.12	7.82
Renal Glomerular Endothelial Cells, donor3	11675-122H1	13.10	9.99
Renal Glomerular Endothelial Cells, donor4	11783-124B1	8.65	6.65
Renal Mesangial Cells, donor1	11518-119H6	22.67	15.63
Renal Mesangial Cells, donor2	11598-120H5	25.08	18.18
Renal Mesangial Cells, donor3	11679-122H5	12.76	9.15
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.57	9.39
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.01	5.06
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	16.78	14.66
Retinal Pigment Epithelial Cells, donor0	11215-116A9	10.63	10.11
Retinal Pigment Epithelial Cells, donor1	11528-119I7	14.78	8.53
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	13.30	5.77
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	43.43	28.60
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	81.30	50.03
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	199.78	66.04
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	323.09	147.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	95.70	37.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	71.30	31.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	77.41	38.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	100.35	53.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	78.90	30.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	96.15	40.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	72.01	31.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	73.06	31.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	72.93	30.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	68.57	28.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	75.98	33.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	71.91	34.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	71.88	26.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	68.94	32.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	92.83	42.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	64.10	21.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	82.64	33.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	75.81	33.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	60.66	23.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	69.80	30.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	81.35	34.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	70.20	22.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	73.58	31.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	76.29	32.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	84.21	25.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	68.65	30.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	70.39	30.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	57.64	31.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	82.73	25.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	71.86	27.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	71.46	30.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	70.84	30.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	70.95	32.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	81.84	31.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	75.44	32.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	83.89	36.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	83.85	35.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	109.93	55.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	99.16	47.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	69.55	23.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	72.38	34.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	125.96	55.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	78.54	30.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	107.95	45.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	96.71	45.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	78.21	25.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	153.41	78.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	81.53	45.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	73.84	23.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	80.30	43.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	116.52	50.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	66.24	32.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	78.97	38.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	98.56	56.49
Schwann Cells, donor1	11498-119F4	19.56	10.34
Schwann Cells, donor2	11578-120F3	20.41	17.01
Schwann Cells, donor3	11659-122F3	20.16	13.36
Sebocyte, donor1	11220-116B5	23.55	15.34
Sebocyte, donor2	11301-117B5	9.19	10.57
Sebocyte, donor3	11378-118B1	16.90	12.57
Sertoli Cells, donor1	11255-116F4	18.22	11.60
Sertoli Cells, donor2	11333-117F1	16.95	5.65
Skeletal Muscle Cells, donor1	11281-116I3	16.54	7.92
Skeletal Muscle Cells, donor2	11358-117H8	15.18	2.89
Skeletal Muscle Cells, donor3	11430-118G8	11.70	9.20
Skeletal Muscle Cells, donor4	11451-119A2	15.24	11.47
Skeletal Muscle Cells, donor5	11455-119A6	19.47	12.49
Skeletal Muscle Cells, donor6	11459-119B1	20.93	16.16
Skeletal Muscle Satellite Cells, donor1	11240-116D7	44.10	38.31
Skeletal Muscle Satellite Cells, donor2	11321-117D7	38.10	28.25
Skeletal Muscle Satellite Cells, donor3	11397-118D2	21.83	16.57
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	27.04	14.58
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.86	7.96
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.49	4.27
Skin - palm, donor1	10286-104F7	13.43	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.33	5.62
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	21.27	13.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.62	5.71
Small Airway Epithelial Cells, donor1	11256-116F5	10.56	8.90
Small Airway Epithelial Cells, donor2	11334-117F2	9.56	9.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	12.48	12.48
Small Airway Epithelial Cells, donor3	11406-118E2	7.12	8.17
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	19.75	6.48
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	8.23	2.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.11	7.64
Smooth Muscle Cells - Aortic, donor1	11283-116I5	9.50	4.42
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.06	6.69
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.91	10.04
Smooth Muscle Cells - Bladder, donor1	11519-119H7	38.03	14.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.98	5.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	12.63	10.42
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	12.55	8.45
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	36.14	29.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	25.10	19.20
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	16.51	13.24
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	19.85	9.27
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	20.40	7.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	9.09	5.81
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.06	2.38
Smooth Muscle Cells - Colonic, donor1	11239-116D6	26.25	17.84
Smooth Muscle Cells - Colonic, donor2	11320-117D6	18.73	11.62
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.64	16.37
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.97	7.12
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	5.39
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.07	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	15.70	14.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	32.43	19.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	33.71	30.39
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	19.11	16.61
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.83	4.23
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	20.66	16.43
Smooth Muscle Cells - Prostate, donor1	11257-116F6	28.10	13.58
Smooth Muscle Cells - Prostate, donor2	11335-117F3	23.29	11.14
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.79	6.85
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.19	8.74
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	19.50	6.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	7.44	6.05
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	13.13	10.60
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.46	5.95
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	19.17	19.76
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	38.24	32.41
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	36.91	20.56
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.35	6.76
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	8.16	6.37
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.96	4.89
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	29.77	19.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	21.70	17.60
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	6.67
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	8.32	8.32
Smooth Muscle Cells - Uterine, donor1	11258-116F7	18.56	18.56
Smooth Muscle Cells - Uterine, donor3	11466-119B8	18.73	13.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	19.63	6.61
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.81	9.78
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	36.82	18.97
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	30.54	26.59
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.05	17.32
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	19.30	7.09
Smooth muscle cells - airway, control, donor1	11966-126D4	22.60	13.97
Smooth muscle cells - airway, control, donor2	11967-126D5	28.75	13.18
Smooth muscle cells - airway, control, donor3	11968-126D6	24.24	7.94
Smooth muscle cells - airway, control, donor4	11969-126D7	22.92	11.00
Synoviocyte, donor1	11291-117A4	18.35	12.29
Synoviocyte, donor2	11368-117I9	20.28	12.91
Synoviocyte, donor3	11440-118H9	22.34	5.59
Trabecular Meshwork Cells, donor1	11532-120A2	24.30	25.37
Trabecular Meshwork Cells, donor2	11612-122A1	25.77	31.71
Trabecular Meshwork Cells, donor3	11693-123A1	14.12	17.13
Tracheal Epithelial Cells, donor1	11292-117A5	7.46	6.81
Tracheal Epithelial Cells, donor2	11369-118A1	6.19	5.80
Tracheal Epithelial Cells, donor3	11441-118I1	3.44	5.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	42.81	29.28
Urethra, donor2	10319-105A4	10.79	5.40
Urothelial Cells, donor1	11520-119H8	11.69	7.97
Urothelial Cells, donor2	11600-120H7	6.01	6.01
Urothelial Cells, donor3	11681-122H7	6.88	6.19
Urothelial cells, donor0	11216-116B1	14.71	15.60
Whole blood (ribopure), donor090309, donation1	12179-129A1	51.61	43.60
Whole blood (ribopure), donor090309, donation2	12180-129A2	54.33	48.61
Whole blood (ribopure), donor090309, donation3	12181-129A3	41.76	35.60
Whole blood (ribopure), donor090325, donation1	12176-128I7	40.98	39.94
Whole blood (ribopure), donor090325, donation2	12177-128I8	43.00	40.67
Whole blood (ribopure), donor090612, donation1	12182-129A4	38.53	22.91
Whole blood (ribopure), donor090612, donation2	12183-129A5	67.00	47.73
Whole blood (ribopure), donor090612, donation3	12184-129A6	35.60	35.60
Wilms' tumor cell line:G-401	10809-111A8	14.43	15.30
Wilms' tumor cell line:HFWT	10597-108E3	13.20	3.52
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.89	5.87
achilles tendon, donor2	10292-104G4	10.33	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	42.58	46.66
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	41.56	29.49
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	30.63	21.60
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	44.35	26.12
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	17.15	12.37
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	42.93	38.70
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	26.68	25.04
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	21.59	18.51
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	53.09	26.54
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	32.23	19.41
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	17.11	10.67
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	23.40
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	39.50	40.20
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	27.70	15.53
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	33.90	12.86
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	26.96	18.59
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	21.80	28.38
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	18.72	14.73
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	50.35	32.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	54.29	28.51
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	57.29	32.74
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	26.95	26.28
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	49.36	32.69
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	72.47	57.60
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	49.34	42.94
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	33.58	11.78
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	58.11	44.99
adenocarcinoma cell line:IM95m	10796-110I4	21.19	15.31
adipose tissue, adult, pool1	10010-101C1	44.83	24.66
adipose, donor1	10184-103D4	41.64	12.90
adipose, donor2	10185-103D5	13.38	10.95
adipose, donor3	10186-103D6	12.25	8.44
adipose, donor4	10187-103D7	8.67	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	41.03	17.04
adrenal gland, adult, pool1	10081-102A9	18.19	21.83
adult T-cell leukemia cell line:ATN-1	10421-106C7	44.29	55.63
alveolar cell carcinoma cell line:SW 1573	10708-109H6	16.44	9.29
amniotic membrane cells, donor1	12235-129G3	15.30	8.11
amniotic membrane cells, donor2	12236-129G4	8.45	6.76
amniotic membrane cells, donor3	12237-129G5	21.21	10.31
amygdala - adult, donor10196	10167-103B5	35.57	29.64
amygdala, adult, donor10252	10151-102I7	38.32	19.06
amygdala, newborn, donor10223	10360-105E9	16.78	8.39
anaplastic carcinoma cell line:8305C	10428-106D5	20.50	8.40
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	25.37	21.84
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	29.06	9.35
aorta, adult, pool1	10052-101G7	23.93	12.75
appendix, adult	10189-103D9	37.65	29.11
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	41.27	23.73
artery, adult	10190-103E1	54.35	43.48
astrocytoma cell line:TM-31	10425-106D2	53.17	31.15
b cell line:RPMI1788	10427-106D4	18.74	19.33
basal cell carcinoma cell line:TE 354.T	10702-109G9	23.31	16.37
bile duct carcinoma cell line:HuCCT1	10432-106D9	20.84	10.52
bile duct carcinoma cell line:TFK-1	10496-107C1	1.51	1.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	17.90	8.95
bladder, adult, pool1	10011-101C2	33.46	17.27
blood, adult, pool1	10053-101G8	19.93	15.50
bone marrow stromal cell line:StromaNKtert	10686-109F2	57.38	52.24
bone marrow, adult	10192-103E3	51.96	26.99
brain, adult, donor1	10084-102B3	26.65	14.35
brain, adult, pool1	10012-101C3	28.95	12.58
brain, fetal, pool1	10085-102B4	26.71	16.03
breast carcinoma cell line:MCF7	10482-107A5	39.64	24.78
breast carcinoma cell line:MDA-MB-453	10419-106C5	17.60	17.10
breast, adult, donor1	10080-102A8	16.42	10.73
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	11.18	4.07
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	29.69	12.68
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	61.47	34.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	24.93	16.22
carcinoid cell line:NCI-H1770	10703-109H1	25.39	25.39
carcinoid cell line:NCI-H727	10735-110B6	40.58	31.94
carcinoid cell line:SK-PN-DW	10719-109I8	14.26	15.53
carcinosarcoma cell line:JHUCS-1	10642-109A3	25.02	13.58
caudate nucleus - adult, donor10196	10177-103C6	46.05	19.57
caudate nucleus, adult, donor10252	10164-103B2	31.96	17.74
caudate nucleus, adult, donor10258	10379-105H1	42.79	13.75
caudate nucleus, newborn, donor10223	10354-105E3	17.95	8.42
cerebellum - adult, donor10196	10173-103C2	55.35	17.48
cerebellum, adult, donor10252	10166-103B4	45.26	23.06
cerebellum, adult, pool1	10083-102B2	28.98	10.35
cerebellum, newborn, donor10223	10357-105E6	28.23	6.64
cerebral meninges, adult	10188-103D8	31.01	15.13
cerebrospinal fluid, donor2	10294-104G6	14.62	10.96
cervical cancer cell line:D98-AH2	10552-107I3	14.81	14.81
cervical cancer cell line:ME-180	10553-107I4	9.94	11.10
cervix, adult, pool1	10013-101C4	39.48	19.74
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	21.74	10.59
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	11.76
choriocarcinoma cell line:BeWo	10423-106C9	7.83	8.45
choriocarcinoma cell line:SCH	10785-110H2	5.79	6.04
choriocarcinoma cell line:T3M-3	10618-108G6	4.74	5.69
chorionic membrane cells, donor1	12238-129G6	12.54	6.55
chorionic membrane cells, donor2	12239-129G7	22.67	17.20
chorionic membrane cells, donor3	12240-129G8	17.03	9.89
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	23.23	20.20
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	18.63	14.22
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	34.00	29.78
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	35.18	40.32
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	43.54	49.10
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	34.61	41.74
chronic myelogenous leukemia cell line:K562	10454-106G4	36.81	44.46
chronic myelogenous leukemia cell line:KU812	10409-106B4	49.52	48.48
clear cell carcinoma cell line:JHOC-5	10638-108I8	26.97	12.34
clear cell carcinoma cell line:TEN	10636-108I6	4.86	4.51
colon carcinoma cell line:CACO-2	10513-107D9	6.22	2.93
colon carcinoma cell line:COLO-320	10420-106C6	68.03	44.09
colon, adult, donor1	10082-102B1	27.37	8.33
colon, adult, pool1	10014-101C5	39.95	27.03
colon, fetal, donor1	10070-101I7	24.10	14.21
common myeloid progenitor CMP, donor1	12130-128D6	41.25	27.50
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	17.42	7.22
cord blood derived cell line:COBL-a 24h infection	10453-106G3	15.85	7.55
cord blood derived cell line:COBL-a untreated	10449-106F8	15.23	10.01
corpus callosum, adult, pool1	10042-101F6	50.86	19.13
cruciate ligament, donor2	10295-104G7	21.88	8.92
diaphragm, fetal, donor1	10069-101I6	21.67	15.25
diencephalon, adult	10193-103E4	35.04	11.28
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	25.95	21.58
ductal cell carcinoma cell line:KLM-1	10438-106E6	25.39	12.57
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	7.94	19.74
ductus deferens, adult	10196-103E7	30.40	12.96
duodenum, fetal, donor1, tech_rep1	10071-101I8	24.48	17.28
duodenum, fetal, donor1, tech_rep2	10071-101I8	48.55	22.07
dura mater, adult, donor1	10041-101F5	54.92	18.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	8.44	13.77
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	14.62	9.60
embryonic pancreas cell line:1B2C6	10604-108F1	20.35	9.87
embryonic pancreas cell line:1C3D3	10605-108F2	22.40	11.20
embryonic pancreas cell line:1C3IKEI	10606-108F3	18.83	12.04
embryonic pancreas cell line:2C6	10603-108E9	22.33	14.45
endometrial carcinoma cell line:OMC-2	10497-107C2	19.44	12.07
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	29.36	9.06
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	7.40	9.01
epidermoid carcinoma cell line:A431	10426-106D3	22.90	23.01
epidermoid carcinoma cell line:Ca Ski	10431-106D8	20.68	15.18
epididymis, adult	10197-103E8	39.35	16.95
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	29.45	23.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	7.86	5.90
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	9.57	4.06
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	10.63	4.63
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	11.09	4.48
esophagus, adult, pool1	10015-101C6	23.47	20.28
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	37.82	118.72
eye - muscle inferior rectus, donor1	10272-104E2	16.90	2.41
eye - muscle lateral, donor2	10298-104H1	23.15	18.94
eye - muscle medial, donor2	10299-104H2	13.39	13.39
eye - muscle superior, donor2	10297-104G9	20.64	6.88
eye - vitreous humor, donor1	10268-104D7	5.83	10.20
eye, fetal, donor1	10054-101G9	34.07	13.98
fibrosarcoma cell line:HT-1080	10758-110E2	6.92	4.62
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	11.63	7.12
frontal lobe, adult, pool1	10040-101F4	41.28	17.08
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	41.13	30.63
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	48.92	20.30
gall bladder, adult	10198-103E9	47.32	31.39
gamma delta positive T cells, donor1	11937-126A2	87.51	81.60
gamma delta positive T cells, donor2	11938-126A3	80.67	71.34
gastric adenocarcinoma cell line:MKN1	10614-108G2	12.88	8.24
gastric adenocarcinoma cell line:MKN45	10612-108F9	33.07	24.76
gastric cancer cell line:AZ521	10549-107H9	20.82	9.51
gastric cancer cell line:GSS	10560-108A2	38.44	10.98
gastrointestinal carcinoma cell line:ECC12	10615-108G3	37.24	9.14
giant cell carcinoma cell line:LU65	10487-107B1	11.02	7.46
giant cell carcinoma cell line:Lu99B	10433-106E1	29.25	16.66
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.43	19.70
glioblastoma cell line:A172, tech_rep1	10444-106F3	38.21	24.59
glioblastoma cell line:A172, tech_rep2	10444-106F3	37.22	20.22
glioblastoma cell line:T98G	10485-107A8	33.33	17.33
glioma cell line:GI-1	10413-106B8	18.16	11.13
globus pallidus - adult, donor10196	10175-103C4	34.26	10.20
globus pallidus, adult, donor10252	10161-103A8	62.49	34.17
globus pallidus, adult, donor10258	10367-105F7	20.54	10.95
globus pallidus, newborn, donor10223	10364-105F4	23.45	10.66
granulocyte macrophage progenitor, donor1	12131-128D7	26.92	17.13
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	15.68
granulosa cell tumor cell line:KGN	10624-108H3	16.64	9.92
hIPS +CCl2, biol_rep1	14383-156B9	5.51	0.92
hIPS +CCl2, biol_rep2	14384-156C1	5.94	5.03
hIPS +CCl2, biol_rep3	14385-156C2	6.44	1.29
hIPS, biol_rep1	14380-156B6	2.87	0.00
hIPS, biol_rep2	14381-156B7	4.80	0.00
hIPS, biol_rep3	14382-156B8	36.41	16.55
hairy cell leukemia cell line:Mo	10712-109I1	37.64	21.84
heart - mitral valve, adult	10205-103F7	52.92	26.31
heart - pulmonic valve, adult	10206-103F8	65.37	33.47
heart - tricuspid valve, adult	10207-103F9	19.15	15.82
heart, adult, diseased post-infarction, donor1	10050-101G5	23.87	17.75
heart, adult, diseased, donor1	10051-101G6	37.47	38.32
heart, adult, pool1	10016-101C7	61.86	60.02
heart, fetal, pool1	10046-101G1	59.97	33.58
hepatic mesenchymal tumor cell line:LI90	10778-110G4	12.65	8.02
hepatoblastoma cell line:HuH-6	10633-108I3	3.57	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	19.45	10.94
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	16.39	11.65
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	22.43	11.92
hepatoma cell line:Li-7	10484-107A7	14.24	8.90
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	18.69	17.19
hippocampus - adult, donor10196	10169-103B7	28.39	10.41
hippocampus, adult, donor10252	10153-102I9	42.04	24.29
hippocampus, adult, donor10258	10374-105G5	28.38	14.44
hippocampus, newborn, donor10223	10363-105F3	22.21	8.46
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	6.71	7.93
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.11	6.68
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	8.38	6.86
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	9.59	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	13.43	5.94
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	18.22	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	25.11	7.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	24.13	9.26
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	15.85	5.84
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	28.18	13.73
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	24.75	12.70
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	28.95	12.79
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	4.07	7.82
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	7.37	6.39
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.98	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	25.01	8.02
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	28.34	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	24.49	9.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	17.14	11.12
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	25.46	10.46
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	21.93	11.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	27.76	14.21
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	29.61	16.55
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	22.72	12.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	6.65	6.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	7.42	7.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	6.53	8.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	23.24	9.15
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.79	6.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	19.37	7.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.62	6.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	22.58	15.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	30.78	12.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	24.54	12.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	31.80	18.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	21.51	18.82
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	8.21	4.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	7.13	11.59
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	7.32	3.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	16.81	7.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	130.13	32.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	25.81	7.94
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	31.20	8.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	22.07	12.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	32.03	8.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	31.03	8.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	40.36	18.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	22.36	15.36
immature langerhans cells, donor1	11904-125F5	13.32	12.35
immature langerhans cells, donor2	11905-125F6	19.01	11.88
insula, adult, pool1	10039-101F3	42.02	18.17
keratoacanthoma cell line:HKA-1	10791-110H8	5.85	8.45
kidney, adult, pool1	10017-101C8	28.14	18.02
kidney, fetal, pool1	10045-101F9	25.54	10.61
large cell lung carcinoma cell line:IA-LM	10509-107D5	46.87	28.69
large cell lung carcinoma cell line:NCI-H460	10839-111E2	21.57	10.09
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	11.38	9.73
left atrium, adult, donor1	10079-102A7	27.79	16.89
left ventricle, adult, donor1	10078-102A6	26.29	30.84
leiomyoblastoma cell line:G-402	10721-110A1	10.67	18.06
leiomyoma cell line:10964C	10569-108B2	17.24	10.78
leiomyoma cell line:15242A	10570-108B3	14.13	11.96
leiomyoma cell line:15425	10571-108B4	21.12	12.87
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	12.70
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	8.36
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	25.62	38.96
liposarcoma cell line:KMLS-1	10782-110G8	19.68	10.93
liposarcoma cell line:SW 872	10726-110A6	22.42	9.38
liver, adult, pool1	10018-101C9	35.01	19.61
liver, fetal, pool1	10086-102B5	15.99	4.70
locus coeruleus - adult, donor10196	10182-103D2	25.37	9.48
locus coeruleus, adult, donor10252	10165-103B3	33.77	14.58
locus coeruleus, adult, donor10258	10375-105G6	19.19	6.49
locus coeruleus, newborn, donor10223	10362-105F2	23.98	10.09
lung adenocarcinoma cell line:A549	10499-107C4	13.42	6.23
lung adenocarcinoma cell line:PC-14	10408-106B3	24.82	19.99
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	61.29	41.39
lung, adult, pool1	10019-101D1	32.84	25.63
lung, fetal, donor1	10068-101I5	101.32	45.09
lung, right lower lobe, adult, donor1	10075-102A3	21.54	13.75
lymph node, adult, donor1	10077-102A5	26.51	16.09
lymphangiectasia cell line:DS-1	10727-110A7	35.73	31.34
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	31.09	54.64
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	18.69	6.80
mature adipocyte, donor1	12231-129F8	77.70	41.29
mature adipocyte, donor2	12232-129F9	74.71	38.39
mature adipocyte, donor3	12233-129G1	75.39	35.32
mature adipocyte, donor4	12234-129G2	83.44	45.80
maxillary sinus tumor cell line:HSQ-89	10414-106B9	38.84	13.82
medial frontal gyrus - adult, donor10196	10170-103B8	42.87	15.79
medial frontal gyrus, adult, donor10252	10150-102I6	36.97	19.86
medial frontal gyrus, adult, donor10258	10368-105F8	14.30	10.48
medial frontal gyrus, newborn, donor10223	10352-105E1	31.56	18.34
medial temporal gyrus - adult, donor10196	10183-103D3	38.64	16.54
medial temporal gyrus, adult, donor10252	10156-103A3	42.44	19.74
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	25.04	13.48
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	186.60	129.18
medial temporal gyrus, newborn, donor10223	10353-105E2	18.66	10.05
medulla oblongata - adult, donor10196	10174-103C3	25.31	10.38
medulla oblongata, adult, donor10252	10155-103A2	37.77	21.83
medulla oblongata, adult, pool1	10038-101F2	33.06	15.26
medulla oblongata, newborn, donor10223	10361-105F1	25.00	13.89
medulloblastoma cell line:D283 Med	10838-111E1	35.87	24.58
medulloblastoma cell line:ONS-76	10759-110E3	16.63	9.29
melanoma cell line:COLO 679	10514-107E1	25.30	21.42
melanoma cell line:G-361	10465-106H6	26.60	12.22
meningioma cell line:HKBMM	10691-109F7	11.76	7.06
merkel cell carcinoma cell line:MKL-1	10843-111E6	30.84	13.22
merkel cell carcinoma cell line:MS-1	10844-111E7	35.51	13.22
mesenchymal precursor cell - adipose, donor1	11747-123G1	23.63	11.35
mesenchymal precursor cell - adipose, donor2	11748-123G2	18.00	8.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	26.09	8.70
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	20.51	15.87
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.98	10.21
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	27.07	18.05
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.13	7.21
mesenchymal precursor cell - cardiac, donor2	11753-123G7	13.11	5.98
mesenchymal precursor cell - cardiac, donor3	11754-123G8	18.57	9.02
mesenchymal precursor cell - cardiac, donor4	11755-123G9	14.18	5.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	13.37	8.11
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	11.53	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.57	8.86
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	35.26	17.45
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	14.70	10.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.22	3.24
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	16.03	5.17
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.26	6.84
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	32.73	18.04
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	15.39	9.71
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	10.33	6.21
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	19.14	7.73
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	17.74	12.88
mesenchymal stem cell line:Hu5/E18	10568-108B1	42.94	30.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	25.57	10.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	21.74	10.49
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	23.30	8.38
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.34	11.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	24.48	10.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	24.37	12.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.83	11.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	28.73	10.66
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	38.65	13.27
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	29.45	11.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	25.00	11.06
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	34.47	11.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	32.89	10.74
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	30.29	10.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	26.63	14.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	10.94
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	27.93	10.39
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	7.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	24.52	8.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.99	11.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	23.32	14.38
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	25.18	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	25.83	10.93
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	27.28	9.49
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	24.37	10.97
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	29.77	10.77
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	25.52	21.73
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	23.64
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	20.66
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	17.93	15.08
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	31.78	16.68
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	14.74
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	19.64	14.03
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	14.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	10.64
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	17.98
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.03	17.21
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	28.20	13.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	24.67	8.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	18.45	10.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	20.96	16.93
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	43.61	17.44
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	21.54
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.85	12.14
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	18.08
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	19.77	11.53
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	19.05	8.33
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	15.90	7.14
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	8.15
mesodermal tumor cell line:HIRS-BM	10696-109G3	46.42	30.17
mesothelioma cell line:ACC-MESO-1	10493-107B7	26.70	11.34
mesothelioma cell line:ACC-MESO-4	10494-107B8	14.36	13.90
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	13.15	8.22
mesothelioma cell line:Mero-25	10850-111F4	9.53	7.72
mesothelioma cell line:Mero-41	10851-111F5	18.34	7.33
mesothelioma cell line:Mero-48a	10852-111F6	40.52	37.42
mesothelioma cell line:Mero-82	10853-111F7	15.77	15.51
mesothelioma cell line:Mero-83	10854-111F8	16.68	12.26
mesothelioma cell line:Mero-84	10855-111F9	6.57	4.55
mesothelioma cell line:Mero-95	10856-111G1	16.36	12.22
mesothelioma cell line:NCI-H2052	10847-111F1	18.06	8.12
mesothelioma cell line:NCI-H226	10846-111E9	11.58	8.14
mesothelioma cell line:NCI-H2452	10848-111F2	10.76	4.78
mesothelioma cell line:NCI-H28	10845-111E8	9.67	3.82
mesothelioma cell line:No36	10857-111G2	3.26	0.65
mesothelioma cell line:ONE58	10858-111G3	20.59	4.34
migratory langerhans cells, donor1	11901-125F2	43.18	27.06
migratory langerhans cells, donor2	11902-125F3	36.76	18.07
migratory langerhans cells, donor3	11903-125F4	48.46	33.56
mixed mullerian tumor cell line:HTMMT	10689-109F5	19.92	21.22
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	8.05	3.39
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	9.68	5.99
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	24.74	12.75
myelodysplastic syndrome cell line:SKM-1	10772-110F7	64.68	79.09
myeloma cell line:PCM6	10474-106I6	39.53	32.42
myxofibrosarcoma cell line:MFH-ino	10600-108E6	41.09	28.41
myxofibrosarcoma cell line:NMFH-1	10684-109E9	28.83	17.85
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.57	4.12
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.59	2.94
nasal epithelial cells, donor2	12227-129F4	8.28	3.86
neuroblastoma cell line:CHP-134	10508-107D4	28.76	10.12
neuroblastoma cell line:NB-1	10539-107G8	39.48	30.49
neuroblastoma cell line:NBsusSR	10607-108F4	15.18	11.18
neuroblastoma cell line:NH-12	10555-107I6	25.72	6.52
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	78.76	16.13
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	26.77	12.35
neuroectodermal tumor cell line:TASK1	10774-110F9	18.92	13.69
neuroepithelioma cell line:SK-N-MC	10728-110A8	26.07	10.17
neurofibroma cell line:Hs 53.T	10729-110A9	11.98	4.79
neutrophil PMN, donor1	12133-128D9	0.00	0.00
neutrophil PMN, donor2	12137-128E4	92.96	39.84
neutrophil PMN, donor3	12141-128E8	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	32.81	35.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	110.47	51.23
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	16.03	11.22
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	30.48	19.44
nucleus accumbens, adult, pool1	10037-101F1	40.68	15.47
occipital cortex - adult, donor10196	10172-103C1	39.15	18.54
occipital cortex, adult, donor10252	10163-103B1	39.45	19.32
occipital cortex, newborn, donor10223	10355-105E4	29.48	13.83
occipital lobe, adult, donor1	10076-102A4	35.42	14.43
occipital lobe, fetal, donor1	10073-102A1	33.04	11.16
occipital pole, adult, pool1	10036-101E9	29.33	12.38
olfactory region, adult	10195-103E6	31.71	16.24
optic nerve, donor1	10277-104E7	32.02	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	6.95	6.72
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	12.09	6.32
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	13.21	5.59
oral squamous cell carcinoma cell line:SAS	10544-107H4	5.08	2.43
osteoclastoma cell line:Hs 706.T	10704-109H2	13.52	6.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	53.26	33.64
osteosarcoma cell line:HS-Os-1	10558-107I9	35.20	18.45
ovary, adult, pool1	10020-101D2	36.25	21.05
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	19.43	13.02
pancreas, adult, donor1	10049-101G4	15.99	8.47
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1.96	2.52
papillary adenocarcinoma cell line:8505C	10437-106E5	10.56	5.11
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	18.38	10.93
paracentral gyrus, adult, pool1	10035-101E8	34.50	13.73
parietal cortex, adult, donor10258	10373-105G4	37.43	12.48
parietal lobe - adult, donor10196	10171-103B9	31.98	15.05
parietal lobe, adult, donor10252	10157-103A4	35.34	22.52
parietal lobe, adult, pool1	10034-101E7	36.39	15.07
parietal lobe, fetal, donor1	10072-101I9	27.16	4.85
parietal lobe, newborn, donor10223	10356-105E5	28.04	11.96
parotid gland, adult	10199-103F1	30.83	17.27
penis, adult	10200-103F2	42.43	17.19
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	13.57	8.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	11.66	7.28
pineal gland - adult, donor10196	10179-103C8	37.41	23.22
pineal gland, adult, donor10252	10160-103A7	77.58	43.82
pineal gland, adult, donor10258	10377-105G8	61.45	22.57
pituitary gland - adult, donor10196	10180-103C9	50.59	32.38
pituitary gland, adult, donor10252	10162-103A9	64.11	48.47
pituitary gland, adult, donor10258	10378-105G9	46.82	20.43
placenta, adult, pool1	10021-101D3	14.30	8.49
plasma cell leukemia cell line:ARH-77	10840-111E3	27.94	25.03
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	23.35	8.25
pons, adult, pool1	10033-101E6	24.62	9.21
postcentral gyrus, adult, pool1	10032-101E5	35.31	13.34
promyelocytes/myelocytes PMC, donor1	12132-128D8	25.10	8.37
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	23.47
prostate cancer cell line:DU145	10490-107B4	40.64	23.01
prostate cancer cell line:PC-3	10439-106E7	23.60	13.25
prostate, adult, pool1	10022-101D4	32.01	19.95
putamen, adult, donor10196	10176-103C5	50.75	24.31
putamen, adult, donor10252	10152-102I8	27.45	13.73
putamen, adult, donor10258, tech_rep1	10372-105G3	17.48	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	44.94	19.81
putamen, newborn, donor10223	10365-105F5	38.23	16.49
rectal cancer cell line:TT1TKB	10469-106I1	11.06	8.15
rectum, fetal, donor1	10067-101I4	22.26	8.35
renal cell carcinoma cell line:OS-RC-2	10411-106B6	37.10	15.26
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	14.08	12.01
retina, adult, pool1	10030-101E3	50.89	20.87
retinoblastoma cell line:Y79	10475-106I7	20.52	7.27
rhabdomyosarcoma cell line:KYM-1	10787-110H4	18.20	18.20
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	52.87	30.09
sacrococcigeal teratoma cell line:HTST	10695-109G2	30.31	15.91
salivary acinar cells, donor1	11771-123I7	11.33	12.30
salivary acinar cells, donor2	11772-123I8	17.49	13.63
salivary acinar cells, donor3	11773-123I9	24.50	27.14
salivary gland, adult, pool1	10093-102C3	35.46	9.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	26.56	17.12
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	26.10	15.52
seminal vesicle, adult	10201-103F3	28.57	15.87
serous adenocarcinoma cell line:JHOS-2	10639-108I9	20.16	14.58
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	20.63	4.53
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	25.09	19.07
serous cystadenocarcinoma cell line:HTOA	10693-109F9	8.87	5.78
signet ring carcinoma cell line:Kato III	10436-106E4	19.34	8.40
signet ring carcinoma cell line:NUGC-4	10483-107A6	14.06	5.29
skeletal muscle - soleus muscle, donor1	10282-104F3	22.70	46.82
skeletal muscle, adult, pool1	10023-101D5	47.50	58.17
skeletal muscle, fetal, donor1	10066-101I3	20.10	9.05
skin, adult, donor1	10074-102A2	13.57	20.36
skin, fetal, donor1	10065-101I2	37.87	18.31
small cell cervical cancer cell line:HCSC-1	10800-110I8	15.68	5.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	34.67	15.76
small cell lung carcinoma cell line:DMS 144	10841-111E4	29.30	7.32
small cell lung carcinoma cell line:LK-2	10541-107H1	34.12	16.98
small cell lung carcinoma cell line:NCI-H82	10842-111E5	29.92	12.06
small cell lung carcinoma cell line:WA-hT	10562-108A4	44.46	21.14
small intestine, adult, pool1	10024-101D6	36.91	22.46
small intestine, fetal, donor1	10064-101I1	23.83	10.32
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	39.49	12.31
smooth muscle, adult, pool1	10048-101G3	26.88	12.66
somatostatinoma cell line:QGP-1	10781-110G7	45.56	28.14
spinal cord - adult, donor10196	10181-103D1	21.79	7.11
spinal cord, adult, donor10252	10159-103A6	42.19	27.60
spinal cord, adult, donor10258	10369-105F9	31.82	9.69
spinal cord, fetal, donor1	10056-101H2	43.30	17.69
spinal cord, newborn, donor10223	10359-105E8	40.87	21.12
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	14.94	7.02
spleen, adult, pool1	10025-101D7	30.84	30.29
spleen, fetal, pool1	10044-101F8	32.81	21.29
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	21.53	14.80
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	24.30	20.32
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	19.92	14.68
squamous cell carcinoma cell line:T3M-5	10616-108G4	16.42	24.63
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	18.91	13.84
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	22.45	13.13
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	20.31	13.12
stomach, fetal, donor1	10062-101H8	37.38	11.75
submaxillary gland, adult	10202-103F4	30.76	19.94
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	44.03	25.96
substantia nigra, adult, donor10258	10371-105G2	31.04	10.86
substantia nigra, newborn, donor10223	10358-105E7	18.37	5.65
synovial sarcoma cell line:HS-SY-II	10441-106E9	37.37	35.54
temporal lobe, adult, pool1	10031-101E4	31.87	12.12
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	42.74	19.23
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	51.87	21.98
tenocyte, donor1	11763-123H8	34.56	16.76
tenocyte, donor2	11765-123I1	23.27	15.26
tenocyte, donor3	11768-123I4	31.14	10.38
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	14.79	9.86
teratocarcinoma cell line:NCR-G1	10798-110I6	19.58	8.17
teratocarcinoma cell line:PA-1	10807-111A6	9.76	8.37
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1.14	3.17
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	4.54	3.78
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	2.07	8.51
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	8.47	17.26
testis, adult, pool1	10026-101D8	29.21	19.22
testis, adult, pool2	10096-102C6	27.97	20.30
thalamus - adult, donor10196	10168-103B6	29.81	7.73
thalamus, adult, donor10252	10154-103A1	51.89	23.44
thalamus, adult, donor10258, tech_rep1	10370-105G1	20.02	12.32
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.82	6.42
thalamus, newborn, donor10223	10366-105F6	9.21	7.48
throat, adult	10209-103G2	43.69	29.96
throat, fetal, donor1	10061-101H7	28.95	14.93
thymic carcinoma cell line:Ty-82	10803-111A2	16.69	9.54
thymus, adult, pool1	10027-101D9	43.94	32.81
thymus, fetal, pool1	10043-101F7	38.03	36.57
thyroid carcinoma cell line:KHM-5M	10776-110G2	23.27	12.23
thyroid carcinoma cell line:TCO-1	10783-110G9	18.16	6.57
thyroid, adult, pool1	10028-101E1	44.32	32.75
thyroid, fetal, donor1	10060-101H6	25.31	14.24
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	6.16
tongue, adult	10203-103F5	36.05	18.37
tongue, fetal, donor1	10059-101H5	35.86	25.22
tonsil, adult, pool1	10047-101G2	41.77	33.96
trachea, adult, pool1	10029-101E2	26.91	19.80
trachea, fetal, donor1	10058-101H4	23.85	10.39
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	17.36	10.98
transitional-cell carcinoma cell line:5637	10418-106C4	14.08	7.50
transitional-cell carcinoma cell line:JMSU1	10492-107B6	30.71	17.55
tridermal teratoma cell line:HGRT	10694-109G1	15.22	15.22
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	20.65	13.12
umbilical cord, fetal, donor1	10057-101H3	31.30	14.61
uterus, adult, pool1	10100-102D1	46.92	15.70
uterus, fetal, donor1	10055-101H1	25.60	10.75
vagina, adult	10204-103F6	26.49	29.08
vein, adult	10191-103E2	41.43	41.65
xeroderma pigentosum b cell line:XPL 17	10563-108A5	18.96	13.08